PTGS2 and neoplasm: The COX2/PGE2/EP signaling pathway suppresses DCs and NK cells and inhibits T cell production and responsiveness of IL-2 that limits both activation and expansion of cytolytic T cells and promotes tumor immune evasion, suggesting that COX2 blockade could restore tumor immune surveillance (11, 16).